OPINION

Magnetic resonance imaging for predicting personalized antitumor nanomedicine efficacy

Naumenko VA1, Garanina AS2, Vodopyanov SS1, Nikitin AA1,2, Prelovskaya AO1, Demihov EI4, Abakumov MA1,3, Majouga AM1,2,5, Chekhonin VP3
About authors

1 Laboratory of Biomedical Nanomaterials National University of Science and Technology MISiS, Moscow

2 Research Laboratory of Tissue-Specific Ligands, Faculty of Chemistry Federal State Budget Educational Institution of Higher Education MV Lomonosov Moscow State University, Moscow

3 Pirogov Russian National Research Medical University, Moscow, Russia

4 Lebedev Physical Institute, Russian Academy of Sciences, Moscow

5 Mendeleyev University of Chemical Technology of Russia, Moscow

Correspondence should be adressed: Viktor A. Naumenko
Leninsky 4, Moscow, 119049; moc.liamg@tciv.oknemuan

About paper

Funding: the study was financially supported by the Ministry of Education and Science of the Russian Federation under the Federal Targeted Programme for Research and Development in Priority Areas of Development of the Russian Scientific and Technological Complex for 2014–2020, Agreement #14.575.21.0147 of 27.09.2017 (Agreement ID RFMEFI57517X0147).

Received: 2018-08-30 Accepted: 2018-09-25 Published online: 2018-12-31
|
No data available...